BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Mar 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-03-04

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-04	Common Stock	M	4000	$17.86	Acquired	50200	Direct
2013-03-04	Common Stock	S	4000	$60.1811	Disposed	46200	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-04	Stock Option (right to buy) Common Stock	$17.86	M	4000	Disposed	2018-12-16	Common Stock (4000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $60.25 to $60.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vests 6/48ths on June 17, 2009 and 1/48th on the 17th day of every month thereafter.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.